Alpen Route Asset Management
VC Fund
Seoul, South Korea
Alpen Route Asset Management is a VC fund in Seoul focused on Health Care and Medical. Alpen Route Asset Management is finding companies in their focused business and helping them to grow the value as a partner. It invites partners who they can enjoy walking with so that they put emphasis on the mission, strategy, core competence, and the management team of the company when it comes to the investment decisions. The firm activelyseeks Hetero synergies across different sectors in the journey of walking together as an AlpenRoute’ team. It capitalizes on the experiences of challenges and successes, creates a financial culture that builds up over time like the rings of trees growing over winter, and shares the fruits of this journey with the clients.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries Alpen Route Asset Management invests in
Stages Alpen Route Asset Management invests in
Countries Alpen Route Asset Management invests in
Investment Focus
Industry
- Health Care 3 (60%)
- Medical 2 (40%)
- Apps 1 (20%)
- Fitness 1 (20%)
- Oncology 1 (20%)
Stage
- Series A 2 (40%)
- Seed 1 (20%)
- Series B 1 (20%)
- Series C 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| MyBenefit operates a digital platform for employee welfare and corporate benefits management. The company provides systems for handling reward programs, discount services, welfare points, and employee support programs through web and mobile applications. | $2.2M / Seed / Jul 02, 2025 | ||
| Xingxing Mobility is a developer of a micro-mobility application designed for providing a safe and stable ride through kickboard. Their platform offers electric kickboard-sharing services to people, enabling customers to move more comfortably and safely. | $4.5M / Series A / Jun 24, 2019 | ||
| Genopsy develops a highly sensitive early cancer diagnosis technology. | $8.5M / Series A / Jun 19, 2019 | ||
| YBSOFT is a medical device company that has developed a solution to stop wheelchairs from rolling away when sitting down or standing up, thereby saving millions of people from falls. YBSOFT wheelchairs use a simple failsafe patented concept: a safety bar or seatbelt that automatically locks the wheelchair’s brakes when the locking mechanism isreleased. Take off your seat belt or open the safety bar, and the brakes are locked. Close the bar or fasten the belt, and the wheels are unlocked. It’s that easy.YBSOFT’s product is the first Korean wheelchair to be approved by the American FDA. The company has more than 60 patent registrations and applications. | $3.5M / Series B / Apr 15, 2019 | ||
| ABL Bio is one of the world's leading biotech research companies focusing on the development of therapeutic drugs for immuno-oncology & neurodegenerative diseases. Their core values are life-improvement, collaboration, innovation and novel therapy. | $65M / Series C / Jun 09, 2018 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Alpen Route Asset Management invest in?
Alpen Route Asset Management invests primarily in Health Care, Medical and Apps startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Alpen Route Asset Management last invest?
The most recent investment recorded for Alpen Route Asset Management closed in Jul 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
